杏國 (4192)
杏國 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$2.02M, up 7.0% from a year earlier. EPS over the last four quarters totals -NT$1.33.
Company profile
Data as of 2026-10-14
- Market
- TPEx-listed
- Industry
- Biotech & Medical Care
- Listed
- 2014-10-28
- Founded
- 2008-06-26
- Paid-in capital
- NT$351.64M
- Common shares issued
- 35,164,500
- Legal name
- 杏國新藥股份有限公司
- Website
- http://www.syncorebio.com
Monthly revenue
Data as of 2026-10-15
| Month | Revenue | MoM | YoY |
|---|---|---|---|
| 2026-09 | NT$2.02M | +9.4% | +7.0% |
| 2026-08 | NT$1.85M | -15.1% | -12.0% |
Year to date: -6.2% vs. last year (Jan–Sep 2026)
Earnings per share (EPS)
Data as of 2026-06-30
| Quarter | EPS (NT$) |
|---|---|
| 2026 Q2 | -0.38 |
| 2026 Q1 | -0.37 |
| 2025 Q4 | -0.35 |
| 2025 Q3 | -0.23 |
| 2025 Q2 | -0.33 |
| 2025 Q1 | -0.39 |
| 2024 Q4 | -0.37 |
| 2024 Q3 | -0.41 |
Last four quarters: -NT$1.33
Dividends
Data as of 2026-10-14
| Period | Cash (NT$) | Stock (NT$) | Ex-dividend | Ex-rights | Paid |
|---|---|---|---|---|---|
| 2025 年度 | 0.00 | 0.00 | — | — | — |
Shareholder structure
Data as of 2026-10-16
| Holding range | Holders | Share of total |
|---|---|---|
| 1–999 shares | 3,006 | 2.9% |
| 1,000–5,000 shares | 1,241 | 7.1% |
| 5,001–10,000 shares | 173 | 3.6% |
| 10,001–15,000 shares | 60 | 2.0% |
| 15,001–20,000 shares | 28 | 1.4% |
| 20,001–30,000 shares | 37 | 2.6% |
| 30,001–40,000 shares | 9 | 0.9% |
| 40,001–50,000 shares | 14 | 1.8% |
| 50,001–100,000 shares | 19 | 3.6% |
| 100,001–200,000 shares | 10 | 4.1% |
| 200,001–400,000 shares | 2 | 1.3% |
| 400,001–600,000 shares | 0 | 0.0% |
| 600,001–800,000 shares | 1 | 1.9% |
| 800,001–1,000,000 shares | 0 | 0.0% |
| 1,000,001+ shares | 2 | 66.6% |
TDCC data for 2026-10-16: 2 holders own more than 1,000 lots (66.6% of shares), and 3,006 hold less than one lot (2.9%).
Institutional net buying (last 20 trading days)
Data as of 2026-04-14
| Date | Foreign | Trust | Dealers | Total |
|---|---|---|---|---|
| 2026-04-14 | 0 | 0 | 0 | 0 |
Unit: lots (1,000 shares). Over the last 20 trading days, institutions were net buyers of 0 lots.
Price (official close)
Data as of 2026-10-19
Last close NT$18.35 (2026-10-19); 52-week range NT$17.50–29.25.
Sources
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Market Observation Post System (MOPS)
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Depository & Clearing Corporation public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
Charts, drawing tools, and the P/E calculator are in the app, free to use.